UK flag Brexit: What We Are (And Aren't) Doing Get the Fool's analysis on what the UK leaving the EU means for investors

Northwest Biotherapeutics


Updates from The Motley Fool

Latest updates on Northwest Biotherapeutics from Fool.com.


Stock Performance

NWBO vs. S&P 500 | 2 Year Performance
View Interactive NWBO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Northwest Biotherapeutics.
Current Price: $0.63
Prev Close: $0.69
Open: $0.64
Bid: $0.62
Ask: $0.85
Day's Range: $0.57 - $0.69
52wk Range: $0.57 - $12.55
Volume: 5,552,730
Avg Vol 776,556
Market Cap: $58.43M
P/E (ttm): -0.79
EPS (ttm): -$0.87
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Northwest Biotherapeutics.
CAPS Rating 1 out of 5
 
40 Outperform
46 Underperform
CAPS All Stars
 
4 Outperform
35 Underperform

How do you think Northwest Biotherapeutics will perform against the market?



You pick for Northwest Biotherapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Northwest Biotherapeutics.

Northwest Biotherapeutics

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Biotech